112 related articles for article (PubMed ID: 38285669)
21. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
Shanmugam V; Muthukrishnan S
J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
[TBL] [Abstract][Full Text] [Related]
22.
Xie S; Yang G; Wu J; Jiang L; Yuan C; Xu P; Huang M; Liu Y; Li J
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38111151
[TBL] [Abstract][Full Text] [Related]
23. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
Elseginy SA
J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
[TBL] [Abstract][Full Text] [Related]
24. Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.
Singh R; Pokle AV; Ghosh P; Ganeshpurkar A; Swetha R; Singh SK; Kumar A
J Biomol Struct Dyn; 2023; 41(13):6089-6103. PubMed ID: 35862656
[TBL] [Abstract][Full Text] [Related]
25. Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.
Berinyuy E; Soliman MES
Interdiscip Sci; 2017 Sep; 9(3):406-418. PubMed ID: 27165479
[TBL] [Abstract][Full Text] [Related]
26. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
27. Quest for selective MMP9 inhibitors: a computational approach.
Shaikh AS; Sethi A; Makhal PN; Rathi B; Kaki VR
J Biomol Struct Dyn; 2023; 41(24):15053-15066. PubMed ID: 36905674
[TBL] [Abstract][Full Text] [Related]
28. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
Shukla R; Singh TR
J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
[TBL] [Abstract][Full Text] [Related]
29. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel small molecule non-peptidomimetic inhibitor for prolyl oligopeptidase through
Shrivastava A; Srivastava S; Malik R; Alam MM; Shaqiquzamman M; Akhter M
J Biomol Struct Dyn; 2020 Mar; 38(5):1292-1305. PubMed ID: 30929611
[TBL] [Abstract][Full Text] [Related]
31. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study.
Islam MR; Osman OI; Hassan WMI
J Biomol Struct Dyn; 2024; 42(1):82-100. PubMed ID: 36995071
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential ATP-competitive cyclin-dependent kinase 1 inhibitors: De novo drug generation, molecular docking, and molecular dynamics simulation.
He F; Wang X; Wu Q; Liu S; Cao Y; Guo X; Yin S; Yin N; Li B; Fang M
Comput Biol Med; 2023 Mar; 155():106645. PubMed ID: 36774892
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening.
Esther Rubavathy SM; Palanisamy K; Priyankha S; Thilagavathi R; Prakash M; Selvam C
J Biomol Struct Dyn; 2023 Nov; 41(19):9492-9502. PubMed ID: 36369945
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel natural MurD ligase inhibitors as potential antimicrobial agents targeting
Tiwari P; Sharma P; Kumar M; Kapil A; Abdul Samath E; Kaur P
J Biomol Struct Dyn; 2022; 40(24):14051-14066. PubMed ID: 34766874
[TBL] [Abstract][Full Text] [Related]
35. Exploring natural compound, Panicutine as leucine-rich repeat kinase 2 inhibitor against Parkinson's disease: a structure-guided approach.
Majrashi TA; Wahab S; Almoyad MAA; Alkhathami AG; Alshahrani MY
J Biomol Struct Dyn; 2023 Oct; ():1-10. PubMed ID: 37837424
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics.
Mahgoub MA; Alnaem A; Fadlelmola M; Abo-Idris M; Makki AA; Abdelgadir AA; Alzain AA
J Biomol Struct Dyn; 2023; 41(14):6775-6788. PubMed ID: 35997154
[TBL] [Abstract][Full Text] [Related]
37. Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening.
Pandey P; Chatterjee S; Berida T; Doerksen RJ; Roy S
J Biomol Struct Dyn; 2022 Jul; 40(11):4832-4849. PubMed ID: 33353500
[TBL] [Abstract][Full Text] [Related]
38. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
39. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.
Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK
J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]